Associations Between Homocysteine, Bone Turnover, BMD, Mortality, and Fracture Risk in Elderly Women
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Homocysteine has been suggested to be a risk factor for fracture, but the causal relationship is not clear. In 996 women from the OPRA study, high homocysteine level was associated with high bone marker levels and low BMD at baseline. During a mean 7-year follow-up, high homocysteine level was associated with mortality, but no clear association to fracture risk existed. Introduction: Recently, the association between high serum homocysteine (Hcy) levels and an increased risk of fracture has been described. Materials and Methods: Hcy levels were measured at baseline in 996 women, all 75 years old. Vitamin B12, folate, serum cross-linking telopeptide of type I collagen (CTX), serum TRACP5b, serum osteocalcin, urine deoxypyridinoline, PTH, areal BMD (aBMD), calcaneal quantitative ultrasound (QUS), and physical performance were assessed at baseline. Fractures and mortality were recorded during a mean follow-up of 7.0 years. Results: Bone marker levels were higher in women with Hcy in the highest quartile compared with all other women (p < 0.05). The most evident correlation between Hcy and a bone marker was seen with CTX (r = 0.19, p < 0.001). aBMD (hip) was 4% lower, QUS was up to 2% lower, and gait speed was 11% slower among women with Hcy in the highest quartile compared with the other women (p < 0.05). During the follow-up, 267 women sustained at least one low-energy fracture (including 69 hip fractures). When women in the highest Hcy quartile were compared with all other women, the hazard ratios (HRs) for sustaining any type of fracture was 1.18 (95% CI, 0.89–1.36) and for hip fracture was 1.50 (95% CI, 0.91–1.94). For the same group of women, the mortality risk was 2.16 (95% CI, 1.58–2.55). Adjustments for confounders did not substantially change these associations. Adjustment for PTH increased the HR for hip fracture to 1.67 (95% CI, 1.01–2.17). Low vitamin B12 or folate was not associated with increased fracture risk or mortality. Conclusions: High Hcy levels were associated with higher bone turnover, poor physical performance, and lower BMD. There was no clear association to fracture risk. The increased mortality among women with high Hcy levels indicates that a high Hcy level may be a marker of frailty.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sato, Y., Honda, Y., Iwamoto, J., Kanoko, T., & Satoh, K. (2005) · JAMA · doi:10.1001/jama.293.9.1082 · Cited by 2 · cited 1×
“Supplementation with vitamin B12 and folate has recently been shown to decrease fracture risk in stroke patients, indicating a possibility that a decrease in Hcy levels could decrease fracture risk.((14)) Contradictory results on the effect of Hcy on BMD have been reported.”
ResultRetractedToole, J. F., Malinow, M. R., Chambless, L. E., Spence, J. D., Pettigrew, L. C., Howard, V. J., Sides, E. G., Wang, C.-H., & Stampfer, M. (2004) · JAMA · doi:10.1001/jama.291.5.565 · Cited by 1,391
Fall-related factors and risk of hip fracture: the EPIDOS prospective study
Dargent-Molina, P., Favier, F., Grandjean, H., Baudoin, C., Schott, A., Hausherr, E., Meunier, P., & Bréart, G. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01440-7 · Cited by 901
Garnero, P., Sornay-Rendu, E., Claustrat, B., & Delmas, P. D. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.8.1526 · Cited by 709
Homocysteine as a Predictive Factor for Hip Fracture in Older Persons
McLean, R. R., Jacques, P. F., Selhub, J., Tucker, K. L., Samelson, E. J., Broe, K. E., Hannan, M. T., Cupples, L. A., & Kiel, D. P. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032739 · Cited by 589
Reliability of four simple, quantitative tests of balance and mobility in healthy elderly females
Franchignoni, F., Tesio, L., Martino, M. T., & Ricupero, C. (1998) · Aging Clinical and Experimental Research · doi:10.1007/bf03339630 · Cited by 217
Cited by
Impact of nutrition on muscle mass, strength, and performance in older adults
for the IOF CSA Nutrition Working Group, Mithal, A., Bonjour, J.-P., Boonen, S., Burckhardt, P., Degens, H., El Hajj Fuleihan, G., Josse, R., Lips, P., Morales Torres, J., et al. (2013) · Osteoporosis International · doi:10.1007/s00198-012-2236-y · Cited by 301
Proton Pump Inhibitors and Risk of Fractures: A Meta-Analysis of 11 International Studies
Yu, E. W., Bauer, S. R., Bain, P. A., & Bauer, D. C. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.01.007 · Cited by 295
Herrmann, M., Peter Schmidt, J., Umanskaya, N., Wagner, A., Taban-Shomal, O., Widmann, T., Colaianni, G., Wildemann, B., & Herrmann, W. (2007) · Clinical Chemical Laboratory Medicine · doi:10.1515/cclm.2007.362 · Cited by 124
“This suggests that 6438 (26) and 6576 (24) person-years of followup are probably not sufficient to elucidate the association between HCY and fracture risk.”
BackgroundResultInfluentialvan Wijngaarden, J. P., Swart, K. M., Enneman, A. W., Dhonukshe-Rutten, R. A., van Dijk, S. C., Ham, A. C., Brouwer-Brolsma, E. M., van der Zwaluw, N. L., Sohl, E., van Meurs, J. B., et al. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.090043 · Cited by 91
Herrmann, M., Umanskaya, N., Traber, L., Schmidt-Gayk, H., Menke, W., Lanzer, G., Lenhart, M., Peter Schmidt, J., & Herrmann, W. (2007) · Clinical Chemical Laboratory Medicine · doi:10.1515/cclm.2007.352 · Cited by 55
“BMD, TRAP, CTx, OC and PINP did not change throughout the study in both groups.”
BackgroundResultInfluentialRandomized Clinical Trial of Homocysteine Level–Lowering Therapy and Fractures
Sawka, A. M., Ray, J. G., Yi, Q., Josse, R. G., & Lonn, E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.19.2136 · Cited by 47
Gommans, J., Yi, Q., Eikelboom, J. W., Hankey, G. J., Chen, C., & Rodgers, H. (2013) · BMC Geriatrics · doi:10.1186/1471-2318-13-88 · Cited by 42
Association of hyperhomocysteinemia with osteoporosis: a systematic review
Salari, P., Larijani, B., & Abdollahi, M. (2008) · Therapy · doi:10.2217/14750708.5.2.215 · Cited by 27
Metadata
- Authors
- Gerdhem, P., Ivaska, K. K., Isaksson, A., Pettersson, K., Väänänen, H. K., Obrant, K. J., & Åkesson, K.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-01-01
- Volume
- 22
- Issue
- 1
- Pages
- 127-134
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2138821459
- Cited by
- 115
- References
- 6
- FWCI
- 9.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.